|
Information on Skyrun Industrial Co., Ltd. |
Skyrun Industrial Co.Limited, established in 2003, a state-controlled company (By Skyrun Corp. & High Hope) in China, specializing in developing, producing and handing raw pharmaceutical material and intermediates. We have expanded a compositive entity from initially only as a small manufacturer. We have extensive knowledge of domestic and international pharmaceutical markets. Our working range can be start from small amount in research stage to big bulk for industrial production. |
Skyrun Industrial Co., Ltd. also offers: (2S)-2-Amino-4-hexynoic acid (2S)-2-Amino-3-(5-fluoro-1H-indol-3-yl)propanoic acid (2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-tritylsulfanylbutanoic acid (2S)-1-(3-Acetylthio-2-methyl-1-oxopropyl)-L-proline (2S)-(-)-2,2'-Oxybis(octahydro-7,8,8-trimethyl-4,7-methanobenzofuran) (2S)-(+)-2-Methylglycidyl 4-nitrobenzoate (2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester (2R,4S,5R)-2-(4-Methoxyphenyl)-N-benzoyl-4-phenyloxazolidine-5-carboxylic acid (2R,4R)-N-Tert-butoxycarbonyl-4-(dicyclohexylphosphino)-2-[(diphenylphosphino)methyl]pyrrolidine (2R,4R)-N-Boc-4-hydroxy-2-methylpyrrolidine (2R,4R)-n-Boc-2-(Fluoromethyl)-4-hydroxypyrrolidine (2R,4R)-4-Hydroxy-2-pyrrolidinemethanol hydrochloride (2R,4R)-2-Hydroxymethyl-4-Boc-amino pyrrolidine.HCl (2R,4R)-1-[(2S)-5-[[Imino(nitroamino)methyl]amino]-2-[[(3-methyl-8-quinolinyl)sulfonyl]amino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid ethyl ester (2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-heptanoic acid (2R,3S/2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol (2R,3S,4S,5S,)-5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexanone (2R,3S)-N-tert-Butoxycarbonyl-3-phenyl isoserine methyl ester (2R,3S)-3-Phenylserine (2R,3S)-3-Phenylpyrrolidine-2-carboxylic acid (2R,3S)-3-Phenylisoserine hydrochloride (2R,3S)-3-Phenylisoserine ethyl ester (2R,3S)-3-(tert-Butoxycarbonylamino)-1-chloro-2-hydroxy-4-phenylbutane (2R,3S)-3-(tert-Butoxycarbonyl)amino-1,2-epoxy-4-phenylbutane (2R,3R,4S,5R,6R)-2-[[(10S,12S,14R,17S)-12-hydroxy-17-[(2R)-2-hydroxy-6 -methyl-hept-5-en-2-yl]-4,4,10,14,17-pentamethyl-2,3,5,6,7,8,9,11,12,1 3,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]- (2R,3R)-3-Boc-Amino-2-hydroxy-5-methylhexanoic acid (2R,3R)-2-Amino-3-methyloxybutanoic acid (2R,3R)-2,3-O-(1-Phenylethylidene)-L-tartaric acid dimethyl ester (2R,3R)-(-)-2,3-Butanediol (2R,3R)-(+)-bis-(Diphenylphosphino)butane (2R)-Hydroxy (4-methylphenyl) acetic acid (2R)-3-Bromo-2-hydroxy-2-methylpropanoic acid (2R)-3-(1,3-Benzodioxol-5-yl)-2-methylpropanal (2R)-2-Methyl-3-pyrrolidin-1-yl-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride (2R)-2-Amino-3-[4-(trifluoromethoxy)phenyl]propanoic acid (2R)-(-)-Glycidyl tosylate (2R)-(-)-2-Methylglycidyl 4-nitrobenzoate (2R)-(-)-2,5-Dihydro-3,6-dimethoxy-2-isopropylpyrazine (2H)1,4-Benzothiazin-3(4H)-one (2E,4Z,7Z)-2,4,7-Tridecatrienal (2E,4R)-4-[(1R,3aS,4E,7a)-4-[(2E)-2-[(3S,5R)-3,5-bis[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethylidene]octahydro-7a-methyl (2E,4E)-2,4-Heptadien-1-ol (2E)-3-(5-Pyrimidinyl)-2-propenoic acid (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane (2alpha,6alpha,8alpha,9abeta)-Octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl-1H-indole-3-carboxylate (2a,6a,8a,9ab)-Hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one (2a,3a,5a,16b,17b)-2,3-Epoxy-16-(1-pyrrolidinyl)androstan-17-ol (2?,3a,5a,16?,17? )-2-(4-morpholiny)-16-(1-pyrrolidinyl)androstane-3,17-diol (24E)-3-Oxo-5¦Á-lanosta-7,9(11),24-triene-26-al
|
|